<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000306505"><TermName>BCX-1777</TermName><TermDefinition><DefinitionText>A substance being studied in the treatment of some types of leukemia and lymphoma. It is a type of purine nucleoside phosphorylase (PNP) inhibitor. Also called forodesine and forodesine hydrochloride.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><SpanishTermName>BCX-1777</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de algunos tipos de leucemia y linfoma. Es un tipo de inhibidor de la enzima purina-nucleósido fosforilasa (PNP). También se llama forodesina y hidrocloruro de forodesina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2003-05-23</DateFirstPublished><DateLastModified>2007-06-19</DateLastModified></GlossaryTerm>
